This is a research trial testing DUR-928 (an experimental medication). The purpose of the trial is to assess whether treatment with DUR-928 has any effect on the treatment of Primary Sclerosing Cholangitis (PSC). This trial will also assess safety (side effects).
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about the DUR-928 Study
View study details on ClinicalTrials.gov
Subjects, 18 y/o and older, with a verified diagnosis of PSC for at least 12 months, with or without IBD.
June 01, 2018